{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T16:25:04Z","timestamp":1788193504455,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","brainanddevelopment.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.braindev.2024.104304","type":"journal-article","created":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T02:47:24Z","timestamp":1731811644000},"page":"104304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Levetiracetam for pediatric migraine prophylaxis: A narrative review"],"prefix":"10.1016","volume":"47","author":[{"given":"Maryam","family":"Shahrokhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Mohammad Davari Fard","family":"Pur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Shafaei-Bajestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibeh","family":"Mashayekhi-sardoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2024.104304_bb0005","doi-asserted-by":"crossref","first-page":"72","DOI":"10.36469\/jheor.2023.87790","article-title":"The hidden economic consequences of migraine to the UK government: burden-of-disease analysis using a fiscal framework","volume":"10","author":"Martins","year":"2023","journal-title":"J Health Econ Outcomes Res"},{"key":"10.1016\/j.braindev.2024.104304_bb0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1474-4422(24)00026-7","article-title":"Genetics of migraine: complexity, implications, and potential clinical applications","volume":"23","author":"Sutherland","year":"2024","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104943","article-title":"Resistant and refractory migraine: clinical presentation, pathophysiology, and management","volume":"99","author":"Ornello","year":"2024","journal-title":"eBioMedicine"},{"key":"10.1016\/j.braindev.2024.104304_bb0020","article-title":"Evaluation of green light exposure on headache frequency and quality of life in migraine patients: a preliminary one-way cross-over clinical trial","volume":"41:333102420956711","author":"Martin","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2514183X18823377","article-title":"Treatment of migraine attacks and prevention of migraine: guidelines by the German migraine and headache society and the German Society of Neurology","volume":"3","author":"Diener","year":"2019","journal-title":"Clin transl neurosci"},{"key":"10.1016\/j.braindev.2024.104304_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0333102417738202","article-title":"Headache classification Committee of the International Headache Society (IHS) the international classification of headache disorders, 3rd edition","volume":"38","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1469-8749.2010.03793.x","article-title":"Prevalence of headache and migraine in children and adolescents: a systematic review of population-based studies","volume":"52","author":"Abu-Arafeh","year":"2010","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0040","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/B978-0-12-823357-3.00029-X","article-title":"Chapter 28 - migraine in children and adolescents: Assessment and diagnosis","author":"Abu-Arafeh","year":"2024"},{"key":"10.1016\/j.braindev.2024.104304_bb0045","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1007\/s10072-022-06178-6","article-title":"Sex and gender differences in migraines: a narrative review","volume":"43","author":"Rossi","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.braindev.2024.104304_bb0050","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.3928\/19382359-20170321-02","article-title":"Childhood headache: a brief review","volume":"46","author":"Blume","year":"2017","journal-title":"Pediatr Ann"},{"key":"10.1016\/j.braindev.2024.104304_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-2982.2006.01072.x","article-title":"Cognitive and behavioural effects of migraine in childhood and adolescence","volume":"26","author":"Riva","year":"2006","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fneur.2018.00078","article-title":"Non-verbal cognitive abilities in children and adolescents affected by migraine and tension-type headache: an observational study using the Leiter-3","volume":"9","author":"Margari","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11916-017-0633-9","article-title":"Primary headaches and school performance-is there a connection?","volume":"21","author":"Genizi","year":"2017","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.braindev.2024.104304_bb0070","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1177\/0333102419867280","article-title":"Hypothalamic regulation of headache and migraine","volume":"39","author":"May","year":"2019","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1129-2377-14-62","article-title":"Cortical spreading depression as a target for anti-migraine agents","volume":"14","author":"Costa","year":"2013","journal-title":"J Headache Pain"},{"key":"10.1016\/j.braindev.2024.104304_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/vision5020030","article-title":"Migraine visual Aura and Cortical spreading depression\u2014linking mathematical models to empirical evidence","volume":"5","author":"O\u2019Hare","year":"2021","journal-title":"Vision"},{"key":"10.1016\/j.braindev.2024.104304_bb0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system—40 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.braindev.2024.104304_bb0090","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/head.13300","article-title":"A phase-by-phase review of migraine pathophysiology","volume":"58","author":"Dodick","year":"2018","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2024.104304_bb0095","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1586\/ern.12.104","article-title":"The pharmacological treatment of migraine in children and adolescents: an overview","volume":"12","author":"Toldo","year":"2012","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.braindev.2024.104304_bb0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/jcpt.12715","article-title":"Efficacy and safety of levetiracetam for migraine prophylaxis: a systematic review","volume":"43","author":"Watkins","year":"2018","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.braindev.2024.104304_bb0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s42399-023-01551-8","article-title":"Efficacy and safety of Levetiracetam on the treatment of spasticity in neurologic disorders: a systematic review","volume":"5","author":"Pascual","year":"2023","journal-title":"SN Compr Clin Med"},{"issue":"Suppl. 2","key":"10.1016\/j.braindev.2024.104304_bb0110","first-page":"49","article-title":"The possibilities of using keppra (levetiracetam) in different neurological diseases","author":"Lebedeva","year":"2008","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"10.1016\/j.braindev.2024.104304_bb0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1574884712666170329094419","article-title":"Levetiracetam in compare to sodium valproate for prophylaxis in chronic migraine headache: a randomized double-blind clinical trial","volume":"12","author":"Kashipazha","year":"2017","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.braindev.2024.104304_bb0120","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.4103\/0028-3886.193801","article-title":"Levetiracetam as an antiepileptic, neuroprotective, and hyperalgesic drug","volume":"64","author":"Cortes-Altamirano","year":"2016","journal-title":"Neurol India"},{"key":"10.1016\/j.braindev.2024.104304_bb0125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/ern.10.3","article-title":"Levetiracetam: a comprehensive review","volume":"10","author":"Crepeau","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.braindev.2024.104304_bb0130","article-title":"Levetiracetam for the prophylaxis of migraine in adults","volume":"13","author":"Azeem","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.braindev.2024.104304_bb0135","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jfma.2020.08.020","article-title":"Efficacy of levetiracetam for migraine prophylaxis: a systematic review and meta-analysis","volume":"120","author":"Yen","year":"2021","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.braindev.2024.104304_bb0140","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1177\/03331024221103815","article-title":"Levetiracetam in the prophylactic treatment of episodic migraine: a prospective open label study","volume":"42","author":"Evers","year":"2022","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1526-4610.2004.04053.x","article-title":"Efficacy and safety of levetiracetam in pediatric migraine","volume":"44","author":"Miller","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2024.104304_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1526-4610.2007.00728.x","article-title":"Levetiracetam prophylaxis in pediatric migraine--an open-label study","volume":"47","author":"Pakalnis","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.braindev.2024.104304_bb0155","first-page":"74","article-title":"Levetiracetam in the treatment of pediatric headache","volume":"9","author":"Awaad","year":"2014","journal-title":"J Taibah Univ Med Sci"},{"issue":"6","key":"10.1016\/j.braindev.2024.104304_bb0160","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.4103\/ATMPH.ATMPH_499_17","article-title":"Prophylactic efficacy of levetiracetam on migraine headaches in children aged 4-14-year-old","volume":"10","author":"Sediqi","year":"2017","journal-title":"Ann Trop Med Public Health"},{"key":"10.1016\/j.braindev.2024.104304_bb0165","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1177\/0333102419851814","article-title":"Levetiracetam for prophylactic treatment of pediatric migraine: a randomized double-blind placebo-controlled trial","volume":"39","author":"Montazerlotfelahi","year":"2019","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.braindev.2024.104304_bb0170","doi-asserted-by":"crossref","first-page":"145","DOI":"10.5114\/polp.2019.86434","article-title":"The efficacy and safety of levetiracetam in the prophylaxis of migraine headaches in children \u2013 a randomised trial","volume":"94","author":"Ghazavi","year":"2019","journal-title":"Pediatr Pol"},{"key":"10.1016\/j.braindev.2024.104304_bb0175","first-page":"105","article-title":"Comparing prophylactic effect of Levetiracetam, sodium valproate, and propranolol in pediatric migraine: a randomized clinical trial","volume":"17","author":"Fayyazi","year":"2023","journal-title":"Iran J Child Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0180","article-title":"Levetiracetam-associated irritability and potential role of vitamin B6 use in veterans with epilepsy","volume":"16","author":"Dreischmeier","year":"2021","journal-title":"Epilepsy Behav Rep"},{"issue":"4","key":"10.1016\/j.braindev.2024.104304_bb0185","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3390\/ph15040475","article-title":"Levetiracetam mechanisms of action: from molecules to systems","volume":"15","author":"Contreras-Garc\u00eda","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.braindev.2024.104304_bb0190","article-title":"Synaptic vesicle glycoprotein 2A: features and functions","volume":"16","author":"Rossi","year":"2022","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1527-3458.2007.00004.x","article-title":"Levetiracetam: the profile of a novel anticonvulsant drug-part I: preclinical data","volume":"13","author":"De Smedt","year":"2007","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.braindev.2024.104304_bb0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/WNR.0000000000001067","article-title":"High-field MRS study of GABA+ in patients with migraine: response to levetiracetam treatment","volume":"29","author":"Li","year":"2018","journal-title":"Neuroreport"},{"key":"10.1016\/j.braindev.2024.104304_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainresbull.2012.10.006","article-title":"Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca2+ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER)","volume":"90","author":"Yan","year":"2013","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.braindev.2024.104304_bb0210","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.0000217303.22856.38","article-title":"Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia","volume":"37","author":"Costa","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.braindev.2024.104304_bb0215","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1523\/JNEUROSCI.23-11-04410.2003","article-title":"Elevation of basal intracellular calcium as a central element in the activation of brain macrophages (microglia): suppression of receptor-evoked calcium signaling and control of release function","volume":"23","author":"Hoffmann","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.braindev.2024.104304_bb0220","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.expneurol.2011.11.017","article-title":"Neuronal death by repetitive cortical spreading depression in juvenile rat brain","volume":"233","author":"Sadeghian","year":"2012","journal-title":"Exp Neurol"},{"key":"10.1016\/j.braindev.2024.104304_bb0225","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1468-2982.2009.01982.x","article-title":"Spreading depression: from serendipity to targeted therapy in migraine prophylaxis","volume":"29","author":"Ayata","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.braindev.2024.104304_bb0230","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-3940(02)01120-5","article-title":"Blockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depression","volume":"334","author":"Richter","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.braindev.2024.104304_bb0235","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1468-2982.2004.00656.x","article-title":"Effects of N-, P\/Q- and L-type calcium channel blockers on nociceptive neurones of the trigeminal nucleus with input from the dura","volume":"24","author":"Ebersberger","year":"2004","journal-title":"Cephalalgia"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760424001578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T12:44:28Z","timestamp":1740141868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760424001578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0387760424001578"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104304","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam for pediatric migraine prophylaxis: A narrative review","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2024.104304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104304"}}